Trial Profile
Phase I trial of Excellair in patients with asthma
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 30 Nov 2010
Price :
$35
*
At a glance
- Drugs Syk kinase silencer (Primary)
- Indications Asthma
- Focus Adverse reactions
- 30 Nov 2010 New trial record